KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Income from Continuing Operations (2016 - 2025)

Charles River Laboratories International has reported Income from Continuing Operations over the past 17 years, most recently at 276290000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 276290000.0 for Q4 2025, down 29.26% from a year ago — trailing twelve months through Dec 2025 was 142163000.0 (down 662.11% YoY), and the annual figure for FY2025 was 142163000.0, down 662.11%.
  • Income from Continuing Operations for Q4 2025 was 276290000.0 at Charles River Laboratories International, down from 55556000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for CRL hit a ceiling of 189106000.0 in Q4 2022 and a floor of 276290000.0 in Q4 2025.
  • Median Income from Continuing Operations over the past 5 years was 92088500.0 (2021), compared with a mean of 62747150.0.
  • Biggest five-year swings in Income from Continuing Operations: skyrocketed 48.94% in 2022 and later crashed 213.12% in 2024.
  • Charles River Laboratories International's Income from Continuing Operations stood at 139827000.0 in 2021, then soared by 35.24% to 189106000.0 in 2022, then fell by 0.08% to 188952000.0 in 2023, then crashed by 213.12% to 213747000.0 in 2024, then fell by 29.26% to 276290000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 276290000.0 (Q4 2025), 55556000.0 (Q3 2025), and 52693000.0 (Q2 2025) per Business Quant data.